ZyLET

Active Ingredient(s): Loteprednol + Tobramycin
FDA Approved: * December 14, 2004
Pharm Company: * BAUSCH AND LOMB
Category: Vision / Eye Health

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



ZyLET Overview

Loteprednol (as the ester loteprednol etabonate) is a corticosteroid used to treat inflammations of the eye. It is marketed by Bausch and Lomb as Lotemax[1] and Loterex. It was patented in 1980 and approved for medical use in 1998.[2] Contents 1 Medical uses 2 Contraindications 3 Adverse effects 4 Interactions 5 Pharmacology 5.1 Mechanism of action 5.2 Pharmacokinetics 5.3 Retrometabolic drug design 6 Chemistry 6.1 Chemical synthesis 7 References 8 Furt...

Read more ZyLET Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Loteprednol

Recent ZyLET Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Loteprednol + Tobramycin
  • Suspension: 0.5% + 0.3%
  • Suspension/drops: 0.5% + 0.3%
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for ZyLET: (1 result)

Sorted by National Drug Code
  • 24208-358 Zylet Ophthalmic Suspension/ Drops by Bausch & Lomb Incorporated

Drugs with one or more similar ingredients: (18 results)